Smith Tiffeny T, Tamma Pranita D, Do Tiffany B, Dzintars Kathryn E, Zhao Yuan, Cosgrove Sara E, Avdic Edina
Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, USA.
Department of Pediatrics, Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Diagn Microbiol Infect Dis. 2018 Jun;91(2):161-163. doi: 10.1016/j.diagmicrobio.2018.01.027. Epub 2018 Feb 3.
We assessed risk factors for and outcomes of linezolid-resistant vancomycin-resistant Enterococcus faecium (LRVREF) bacteremia over 7 years. Thirty-four LRVREF cases were matched to 68 linezolid-susceptible VREF controls. The odds of bacteremia with LRVREF increased by 7% for each additional day of prior linezolid exposure.
我们评估了7年期间耐利奈唑胺耐万古霉素屎肠球菌（LRVREF）菌血症的危险因素和转归。34例LRVREF病例与68例对利奈唑胺敏感的VREF对照进行匹配。既往每增加一天利奈唑胺暴露，LRVREF菌血症的几率增加7%。
